Disturbances of prostacyclin metabolism in children with hemolytic-uremic syndrome and in first degree relatives

S. Túri, T. J. Beattie, J. J F Belch, A. V. Murphy

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Plasma from 24 children with hemolytic uremic syndrome (HUS) (10 in acute, 14 in remission phase), 42 first degree relatives and 24 controls were studied for PGI2 supporting activity (PSA) from human umbilical arterial rings and the concentration of PGI2 metabolite (PGI2m). HUS patients in acute phase showed very low or absent level of plasma PSA, which remained depressed 3 months following presentation. Plasma from 2 out of 5 acute HUS patients showed inhibition against PGI2-like activity, and depressed preservation of PGI2 effect. The mean value of PGI2m in acute phase of HUS patients was elevated initially, but fell below control range by the day 14 and remained decreased at the end of 3rd month. Patients on long term remission showed a significantly lower concentration of plasma PGI2m. Eight of 14 HUS patients in remission and 18 of 42 family members had lower PSA levels than the controls. These studies confirmed a decreased PSA in HUS and suggest that persistently low PSA levels may reflect an inherited predisposition.

Original languageEnglish
Pages (from-to)193-198
Number of pages6
JournalClinical Nephrology
Volume25
Issue number4
Publication statusPublished - 1986

Fingerprint

Hemolytic-Uremic Syndrome
Epoprostenol
Umbilicus
Human Activities

ASJC Scopus subject areas

  • Nephrology

Cite this

Disturbances of prostacyclin metabolism in children with hemolytic-uremic syndrome and in first degree relatives. / Túri, S.; Beattie, T. J.; Belch, J. J F; Murphy, A. V.

In: Clinical Nephrology, Vol. 25, No. 4, 1986, p. 193-198.

Research output: Contribution to journalArticle

Túri, S. ; Beattie, T. J. ; Belch, J. J F ; Murphy, A. V. / Disturbances of prostacyclin metabolism in children with hemolytic-uremic syndrome and in first degree relatives. In: Clinical Nephrology. 1986 ; Vol. 25, No. 4. pp. 193-198.
@article{3d9a8b11fc584b15a56e2c3eb75d1089,
title = "Disturbances of prostacyclin metabolism in children with hemolytic-uremic syndrome and in first degree relatives",
abstract = "Plasma from 24 children with hemolytic uremic syndrome (HUS) (10 in acute, 14 in remission phase), 42 first degree relatives and 24 controls were studied for PGI2 supporting activity (PSA) from human umbilical arterial rings and the concentration of PGI2 metabolite (PGI2m). HUS patients in acute phase showed very low or absent level of plasma PSA, which remained depressed 3 months following presentation. Plasma from 2 out of 5 acute HUS patients showed inhibition against PGI2-like activity, and depressed preservation of PGI2 effect. The mean value of PGI2m in acute phase of HUS patients was elevated initially, but fell below control range by the day 14 and remained decreased at the end of 3rd month. Patients on long term remission showed a significantly lower concentration of plasma PGI2m. Eight of 14 HUS patients in remission and 18 of 42 family members had lower PSA levels than the controls. These studies confirmed a decreased PSA in HUS and suggest that persistently low PSA levels may reflect an inherited predisposition.",
author = "S. T{\'u}ri and Beattie, {T. J.} and Belch, {J. J F} and Murphy, {A. V.}",
year = "1986",
language = "English",
volume = "25",
pages = "193--198",
journal = "Clinical Nephrology",
issn = "0301-0430",
publisher = "Dustri-Verlag Dr. Karl Feistle",
number = "4",

}

TY - JOUR

T1 - Disturbances of prostacyclin metabolism in children with hemolytic-uremic syndrome and in first degree relatives

AU - Túri, S.

AU - Beattie, T. J.

AU - Belch, J. J F

AU - Murphy, A. V.

PY - 1986

Y1 - 1986

N2 - Plasma from 24 children with hemolytic uremic syndrome (HUS) (10 in acute, 14 in remission phase), 42 first degree relatives and 24 controls were studied for PGI2 supporting activity (PSA) from human umbilical arterial rings and the concentration of PGI2 metabolite (PGI2m). HUS patients in acute phase showed very low or absent level of plasma PSA, which remained depressed 3 months following presentation. Plasma from 2 out of 5 acute HUS patients showed inhibition against PGI2-like activity, and depressed preservation of PGI2 effect. The mean value of PGI2m in acute phase of HUS patients was elevated initially, but fell below control range by the day 14 and remained decreased at the end of 3rd month. Patients on long term remission showed a significantly lower concentration of plasma PGI2m. Eight of 14 HUS patients in remission and 18 of 42 family members had lower PSA levels than the controls. These studies confirmed a decreased PSA in HUS and suggest that persistently low PSA levels may reflect an inherited predisposition.

AB - Plasma from 24 children with hemolytic uremic syndrome (HUS) (10 in acute, 14 in remission phase), 42 first degree relatives and 24 controls were studied for PGI2 supporting activity (PSA) from human umbilical arterial rings and the concentration of PGI2 metabolite (PGI2m). HUS patients in acute phase showed very low or absent level of plasma PSA, which remained depressed 3 months following presentation. Plasma from 2 out of 5 acute HUS patients showed inhibition against PGI2-like activity, and depressed preservation of PGI2 effect. The mean value of PGI2m in acute phase of HUS patients was elevated initially, but fell below control range by the day 14 and remained decreased at the end of 3rd month. Patients on long term remission showed a significantly lower concentration of plasma PGI2m. Eight of 14 HUS patients in remission and 18 of 42 family members had lower PSA levels than the controls. These studies confirmed a decreased PSA in HUS and suggest that persistently low PSA levels may reflect an inherited predisposition.

UR - http://www.scopus.com/inward/record.url?scp=0022595935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022595935&partnerID=8YFLogxK

M3 - Article

VL - 25

SP - 193

EP - 198

JO - Clinical Nephrology

JF - Clinical Nephrology

SN - 0301-0430

IS - 4

ER -